Clene (CLNN) EBITDA (2020 - 2026)

Clene has reported EBITDA for 7 years, with the latest figure at -$5.3 million in Q2 2026.

• On a quarterly basis, EBITDA rose 9.37% year-over-year to -$5.3 million in Q2 2026; TTM through Jun 2026 was -$24.4 million, a 7.86% increase from a year earlier, with the FY2025 full-year figure at -$23.1 million, up 30.21% from the prior year.
• EBITDA was -$5.3 million for Q2 2026 at Clene, up from -$7.5 million in the prior quarter.
• The five-year high for EBITDA was -$4.1 million in Q1 2025, with the low at -$13.6 million in Q2 2022.
• Average EBITDA over 5 years is -$8.9 million, with a median of -$9.2 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: EBITDA decreased 13.98% in 2022, then surged 55.59% in 2025.
• Over 5 years, EBITDA stood at -$11.7 million in 2022, then climbed by 14.93% to -$9.9 million in 2023, then rose by 12.77% to -$8.7 million in 2024, then advanced by 13.41% to -$7.5 million in 2025, then rose by 28.71% to -$5.3 million in 2026.
• The last three EBITDA figures came in at -$5.3 million (Q2 2026), -$7.5 million (Q4 2025), and -$5.6 million (Q3 2025), per Business Quant data.